Skip to content

Addiction: all studies

Page 442 of 855: studies 4,411 to 4,420 of 8,547, newest first. Back to the addiction overview

Research

Club drugs: Um Novo Perfil de Abuso de Substâncias em Adolescentes e Jovens Adultos.

Acta Médica Portuguesa October 5, 2022 Diogo Frasquilho Guerreiro, Ana Lisa Carmo, Joaquim Alves da Silva et al. 2 citations

Club drugs are the following substances: Methylenedioxymethamphetamine (MDMA); Methamphetamine; Lysergic Acid Diethylamide (LSD); Ketamine; Gamma-hydroxybutyrate (GHB) and Flunitrazepam. These substances are mainly used by adolescents and young adults, mostly in recreational settings like dance clubs and rave parties. These drugs have diverse psychotropic effects, are associated with several...

Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis

Addiction Science & Clinical Practice October 4, 2022 Adams K. K., Miech E. J., Sobieraj D. M.

Abstract Background Novel buprenorphine dosing strategies have emerged with an aim to transition patients from opioid agonists to buprenorphine without prerequisite opioid withdrawal. We applied a configurational approach to a subset of data from our earlier systematic review to answer the following question: when patients received a buprenorphine initiation strategy aimed to eliminate...

3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs

Frontiers in Psychiatry October 3, 2022 Jordi Camarasa, Pol Puigseslloses, Edurne Urquizu et al. 5 citations

The utility of classical drugs used to treat psychiatric disorders (e.g., antidepressants, anxiolytics) is often limited by issues of lack of efficacy, delayed onset of action or side effects. Psychoactive substances have a long history of being used as tools to alter consciousness and as a gateway to approach the unknown and the divinities. These substances were initially obtained from plants...

Mechanisms underpinning Carpolobia lutea G. Don ethanol extract's neurorestorative and antipsychotic-like activities in an NMDA receptor antagonist model of schizophrenia.

Journal of Ethnopharmacology October 1, 2022 Noah A. Omeiza, A. Bakre, Benneth Ben-Azu et al.

ETHNOPHARMACOLOGICAL RELEVANCE Persistent ketamine insults to the central nervous system block NMDA receptors and disrupt putative neurotransmission, oxido-nitrosative, and inflammatory pathways, resulting in schizophrenia-like symptoms in animals. Previously, the ethnomedicinal benefits of Carpolobia lutea against insomnia, migraine headache, and insanity has been documented, but the...

Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant.

Neuropharmacology October 1, 2022 Atsushi Suzuki, Hiroe Hara, H. Kimura

Ketamine exerts rapid and long-lasting antidepressant effects in patients with treatment-resistant depression. However, its clinical use is limited by its undesirable psychotomimetic side effects. Accumulating evidence from preclinical studies has shown that the antidepressant effects of ketamine are dependent on α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA-R) activation,...

Methylone pre-exposure differentially impacts the aversive effects of MDPV and MDMA in male and female Sprague-Dawley rats: Implications for abuse vulnerability.

Pharmacology, Biochemistry, and Behavior October 2022 Hayley N. Manke, Katharine H Nelson, Shihui Huang et al.

Polydrug use is well documented in synthetic cathinone users, although the consequences of such use are not well characterized. In pre-clinical research, a pre-exposure to a drug has been reported to attenuate the aversive effects of other drugs which has implications for their abuse potential. The goal of the present study was to investigate the impact of pre-exposure to the synthetic...

Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample

Journal of Psychopharmacology October 1, 2022 Grant Jones, Jocelyn A. Ricard, Peter S. Hendricks et al. 7 citations

INTRODUCTION: 3,4-Methylenedioxymethamphetamine (MDMA/"ecstasy") is an empathogen that can give rise to increased pleasure and empathy and may effectively treat post-traumatic stress disorder. Although prior research has demonstrated associations between ecstasy use and favorable mental health outcomes, the associations between ecstasy and physical health have largely been unexplored. Thus, the...

DOI: 10.1177/02698811221127318 (opens in new tab) Ecstasy Odds ratio Population Body mass index +3

If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.

Journal of Pain October 1, 2022 Robert H. Dworkin, Brian T Anderson, Nick Andrews et al. 22 citations

Psychedelic substances have played important roles in diverse cultures, and ingesting various plant preparations to evoke altered states of consciousness has been described throughout recorded history. Accounts of the subjective effects of psychedelics typically focus on spiritual and mystical-type experiences, including feelings of unity, sacredness, and transcendence. Over the past 2 decades,...

The Psychoanalytic Mystic and the Interpretive Word.

Journal of the American Psychoanalytic Association October 1, 2022 Alice Bar Nes 3 citations

Explicit and implicit psychoanalytic assumptions concerning the analytic cure include the old "insight/interpretation" versus "relation/experience" duality. A synthesis of these two stances, grounded in recognition of the long denied yet central mystical facet of psychoanalysis and the crucial role of words in the "talking cure" that psychoanalysis still is, recognizes these two aspects of...

DOI: 10.1177/00030651221124803 (opens in new tab) Full text (opens in new tab) William james Communication Interpretation Intuition +4

Evidence on the impairing effects of Ayahuasca on fear memory reconsolidation.

Psychopharmacology October 1, 2022 Daiane Momo Daneluz, Jeferson Machado Batista Sohn, Gabriela O Silveira et al.

To uncover whether psychedelic drugs attenuate fear memory responses would advance the development of better psychedelic-based treatments for posttraumatic stress disorder (PTSD). Ayahuasca (AYA), a psychedelic brew containing indolamine N, N-dimethyltryptamine (DMT) and β-carbolines, facilitates fear extinction and improves neural plasticity. Upon retrieval, fear memory undergoes labilization...